-
Ariana and FDA Look for Biomarker Signatures
Sept 22 | News Brief | Ariana Pharma and the US Food and Drug Administration (FDA) have entered into a partnership. Ariana Pharma is providing its KEM Biomarker technology to help enable FDA reviewers to analyze pharmacogenomic data combined with patient characteristics for biomarker signatures
Sep 21, 2010
-
Which Way Forward for e-Sourcing?
Sept 21 | eCliniqua | If clinical trial data were sourced electronically rather than on paper, pharmaceutical companies could reap huge savings—most notably by eliminating site monitoring for purposes of source data verification (SDV). Yet e-sourcing remains a relatively rare practice, in part because sites find it inconvenient to enter data directly into electronic data capture (EDC) systems.
Sep 21, 2010
